Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover Tools that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including basic search solutions and advanced search tools comprising Resolute.ai and Scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets. The company also offers Article Galaxy and Article Galaxy Scholar, a solution that allows research organizations to load entitlements, including subscriptions, discount, or token packages, and existing library of articles. In addition, it provides Generative AI, a solution to help researchers understand the quality of the articles they are reviewing, speed up the review process, and to understand how various research papers relate to each other. Further, the company offers references solution, enables researchers to organize literature, collaborate with team members, and access collection of scientific content. Additionally, its platform facilitates the sale of published STM content sold as individual articles. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was incorporated in 2006 and is based in Henderson, Nevada.…
Research Sol. (RSSS) Q1 2027 Earnings Call Transcript
Research Solutions (NASDAQ: RSSS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Software - Application industry, part of the Technology sector, and reports about 141 employees.
The shares were at 2.150 USD on 20 November 2026, down 29.7% over 52 weeks. Its 52-week range is 1.770 USD to 3.380 USD: the price is 36.4% below the high and 21.5% above the low.
At a market capitalisation of 73.41M USD, it trades at 23.9 times trailing earnings and 15.7 times forward earnings. The median trailing P/E of its 18 largest Software - Application peers is 33.6, a discount of 29% for RSSS.
Research Solutions reports return on equity of 13.6%, an operating margin of 7.4% and revenue down 3.3% year over year.
It holds more cash than debt, a net cash position of 12.59M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Buy; their mean price target of 3.750 USD is 74.4% above the current price. The next earnings report is expected on 11 February 2027.